Targeted alpha therapy’s potential to eliminate HIV-infected cells

Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study. The study shows that a specific human antibody labelled with the alpha emitter bismuth-213 can penetrate the blood brain barrier and selectively target and destroy HIV-infected cells while sparing non-infected healthy cells. These findings may open new options for the treatment of HIV associated neurocognitive disorders. —> Read More